[en] Tolerance of the fetal allograft enables the human conceptus to implant itself into the maternal uterus and survive and grow there. This tolerance phenomenon remains largely obscure, notably because it appears to be controlled by multiple mechanisms. CD95 ligand (CD95-L), which can trigger death of CD95-positive cells by apoptosis, may participate in inducing anti-fetus-sensitized CD95-positive T lymphocytes to enter apoptosis. Using immunohistochemistry (first trimester and term placentae), FAGS assays (term placenta) and RT-PCR assays (term placenta), the presence of CD95-L protein and mRNA has been shown in crude placental tissue preparations and isolated placental cells. Among the latter, CD95-L expression was detected in trophoblastic cells, fetal blood cells (mRNA only) and also the Hofbauer macrophages. No CD95-L was detected in fibroblasts or fetal endothelial cells. Thus trophoblastic cells, Hofbauer macrophages, and perhaps also fetal blood cells could form a sequential barrier blocking maternal activated defence cells bearing CD95 molecules. (C) 1998 W. B. Saunders Company Ltd.
Zorzi, Willy ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Histologie humaine
Thellin, Olivier ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Histologie humaine
Coumans, Bernard ; Université de Liège - ULiège > CNCM/ Centre fac. de rech. en neurobiologie cell. et moléc.
Mélot, France ; Université de Liège - ULiège > Services généraux (Faculté de médecine) > Service administratif de la Faculté (Médecine)
Hennen, Georges ; Centre Hospitalier Universitaire de Liège - CHU > Endocrinologie clinique
Lakaye, Bernard ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie humaine et pathologique
Igout, Ahmed ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques
Heinen, Ernst ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Histologie humaine
Language :
English
Title :
Demonstration of the expression of CD95 ligand transcript and protein in human placenta
Anel A, Simon AK, Auphan N, Buferne M, Boyer C, Golstein P & Schmitt-Verhulst AM (1995) Two signaling pathways can lead to Fas ligand expression in CD8+ cytotoxic T lymphocyte clones. Eur J Immunol, 25, 3381-3387.
Ashany D, Song X, Lacy E, Nikolic-Zugic J, Friedman SM & Elkon KB (1995) Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-I antigen pathway. Proc Natl Acad Sci USA, 92, 11225-11229.
Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A & Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature, 377, 630-632.
Bouzahzah F, Bosseloir A, Heinen E & Simar LJ (1995) Human germinal center CD4+CD57+ T cells act differently on B cells than classical T helper cells. De-D Immunol, 4, 189-197.
Chaouat G & Martal J (1996) Cytokines et gestation. In Les cytokines. (Ed.) Cavaillon JM, pp. 471-500. Paris: Masson.
Delgado SR, McBey BA, Yamashiro S, Fujita J, Kiso Y & Croy BA (1996) Accounting for the peripartum loss of granulated metrial gland cells, a natural killer cell population, from the pregnant mouse uterus. J Leuk Biol, 59, 262-269.
Donckier V, Wissing M, Bruyns C, Abramowicz D, Lybin M, Vanderhaeghen ML & Goldman M (1995) Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation, 59, 1571-1576.
Douglas GC & King BF (1989) Isolation of the pure villous cytotrophoblast from term human placenta using immunomagnetic microspheres. J Immunol Methods, 119, 259-268.
Ford AL, Foulcher E, Goodsall AL & Sedgwick JD (1996) Tissue digestion with dispase substantially reduces lymphocyte and macrophage cell-surface antigen expression. J Immunol Methods, 194, 71-75.
French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C & Tschopp J (1996) Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol, 133, 335-343.
Gotlieb WH (1992) Immunologie de la grossesse. Revue Médicale de Bruxelles, 13, 97-101.
Griffith TS, Brunner T, Fletcher SM, Green DR & Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science, 270, 1189-1192.
Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F et al. (1995) FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity, 2, 341-351.
Hahne M, Renno T, Schroeter M, Irmler M, French L, Bornand T, MacDonald HR & Tschopp J (1996) Activated B cells express functional Fas ligand. Eur J Immunol, 26, 721-724.
Hebestreit H, Yousefi S, Balatti I, Weber M, Crameri R, Simon D, Hartung K, Schapowal A, Blaser K & Simon HU (1996) Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur J Immunol, 26, 1775-1780.
Heeg K & Wagner H (1990) Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: transfused class I MHC-incompatible splenocytes veto clonal responses of antigenreactive Lyt-2+ T cells. J Exp Med, 172, 719-728.
Holmes CH, Simpson KL, WainWright SD, Tate CG, Houlihan JM, Sawyer IH, Rogers IP, Spring FA, Anstee D J & Tanner MJ (1990) Preferential expression of the complement regulatory protein Decay Accelerating Factor at the fetomaternal interface during human pregnancy. J Immunol, 144, 3099-3115.
Hutter H, Hammer A, Blaschitz A, Hartmann M, Ebbesen P, Dohr G, Ziegler A & Uchanska-Ziegler B (1996) Expression of HLA class I molecules in human first trimester and term placenta trophoblast. Cell Tissue Res, 286, 439-447.
Jaffe EA (1984) Biology of Endothelial Cells. Boston: Martinus Nijhoff Publishers.
Johnson PM, Risk JM, Mwenda JM et al. (1990) Human trophoblast expression of retroviral like activity and CD46 (membrane cofactor protein, Hu Ly-m5 and H316 TLX antigen). In Reproductive Immunology (Ed.) Mettler L & Billington WD, pp. 125-131. Amsterdam: Elsevier Science.
Jones LA, Chin LT, Merriam GR, Nelson LM & Kruisbeck AM (1990) Failure of clonal deletion in neonatally thymectomized mice: tolerance is preserved through clonal anergy. J Exp Med, 172, 1277-1285.
King A, Boocock C, Sharkey AM, Gardner L, Beretta A, Siccardi AG & Loke YW (1996) Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J Immunol, 156, 2068-2076.
Kliman HK, Nestler JE, Sermasi E, Sanger JM & Strauss III, J F (1986) Purification, characterization and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology, 118, 1567-1582.
Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ & DeMars R (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science, 248, 220-223.
Letellier C, Fizet D, Baltz T & Vezon G (1994) Immunosuppressive activity of sera of pregnant women on cytotoxic T-lymphocyte-mediated cytolysis. I. Characterization of the active fraction. Gynecol Obstet Invest, 37, 1-5.
Lin H, Mossmann TR, Guilbert L, Tuntipopipat S & Wegmann TG (1993) Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol, 151, 4562-4573.
Liu CC, Walsh CM, Eto N, Clark WR & Young JDE (1995) Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells. J Immunol, 155, 602-608.
Lowin B, Hahne M, Mattman C & Tschopp J (1994) Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature, 370, 650-652.
Lowin B, Mattman C, Hahne M & Tschopp J (1996) Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Int Immunol, 8, 57-63.
Luciani MF & Golstein P (1994) Fas-based d10S-mediated cytotoxicity requires macromolecular synthesis for effector cell activation but not for target cell death. Philos Trans R Soc London B: Biol Sci, 345, 303-309.
Maymon R, Zitzer P, Manor Y, Bukovsky I & Moroz C (1995) Placental isoferritin patterns during normal first trimester and tubal gestations. Hum Reprod, 10, 2445-2447.
McLaughlin PJ, Cheng MH, Slade MB & Johnson PM (1982) Expression on cultured human tumour cells of placental trophoblast membrane antigens and placental alkaline phosphatase defined by monoclonal antibodies. Int J Cancer, 30, 21-26.
McLaughlin PJ, Travers PJ, McDicken IW & Johnson PM (1984a) Demonstration of placental and placental-like alkaline phosphatase in non-malignant human tissue extracts using monoclonal antibodies in an enzyme immunoassay. Clin Chem Acta, 137, 341-348.
McLaughlin PJ, Twist AM, Evans CC & Johnson PM (1984b) Serum placental type alkaline phosphatase in cigarette smokers. J Clin Pathol, 37, 826-828.
McLaughlin PJ, Lewis-Jones I, Hutchinson GE & Johnson PM (1986) Placental-type alkaline phosphatase in human seminal plasma from fertile and infertile men. Fert Ster, 46, 934-937.
Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S & Taniguchi N (1992) Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol, 149, 3753-3758.
Morrish DW, Shaw ARE, Seehafer J, Bhardwaj D & Paras M T (1991) Preparation of fibroblast-free cytotrophoblast cultures utilizing differential expression of the CD9 antigen. In Vitro Cell Devl Biol, 27A, 303-306.
Nagata S & Golstein P (1995) The Fas death factor. Science, 267, 1449-1456.
Novelli F, Bernabei P, Ozmen L, Rigamonti L, Allione A, Pestka S, Garotta G & Forni G (1996) Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor. J Immunol, 157, 1935-1943.
Petraglia F, Florio P, Nappi C & Genazzani AR (1996) Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev, 17, 156-186.
Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy M K & Lynch DH (1994) Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol, 6, 1545-1553.
Richardson BC, Lalwani ND, Johnson KJ & Marks RM (1994) Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol, 24, 2640-2645.
Rouvier E, Luciani MF & Golstein P (1993) Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med, 177, 195-200.
Runic R, Lockwood CJ, Ma Y, Dipasquale B & Guller S (1996) Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab, 81, 3119-3122.
Saoudi A, Kuhn J, Huygen K, De Kozak Y, Velu T, Goldman M, Druet P & Bellon B (1993) Th2 activated cells prevent experimental autoimmune uveoretinitis, a Thl-dependent autoimmune disease. Eur J Immunol, 23, 3096-3103.
Schandene L, Ferster A, Mascart-Lemone F, Crusiaux A, Gerard C, Marchant A, Lybin M, Velu T, Sariban E & Goldman M (1993) T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol, 23, 56-60.
Schattner EJ, Mascarenhas J, Bishop J, Yoo DH, Chadburn A, Crow MK & Friedman SM (1996) CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells. Blood, 88, 1375-1382.
Smith MA, Lucie NP & Ferguson M (1986) Progesterone inhibits proliferation of human marrow colony forming cells (CFU-GM) through increased prostaglandin production by marrow macrophages. Br J Haematol, 63, 649-658.
Suda T & Nagata S (1994) Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med, 179, 873-879.
Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K & Nagata S (1995) Expression of the Fas ligand in cells of T cell lineage. J Immunol, 154, 3806-3813.
Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T & Nagata S (1994) Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol, 6, 1567-1574.
Tanaka M, Suda T, Takahashi T & Nagata S (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBOJ, 14, 1129-1135.
Tucek-Szabo CL, Andjelic S, Lacy E, Elkon KB & Nikolic-Zugic J (1996) Activation-induced death can occur without Fas receptor. J Immunol, 156, 192-200.
Uckan D, Steele A, Cherry O, Wang B, Chamizo W, Koutsonikolis A & Good RA (1997) Fas (CD95), Fas ligand (CD95-L), and Bcl-2 expression in human placenta and umbilical cord. J Aller Clin Immunol, 99, S27.
Vaux DL & Strasser A (1996) The molecular biology of apoptosis. Proc Natl Acad Sci USA, 93, 2239-2244.
Vignaux F & Golstein P (1994) Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur J Immunol, 24, 923-927.
Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S & Golstein P (1995) TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med, 181, 781-786.
Webb S, Morris C & Sprent J (1990) Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell, 63, 1249-1256.
Wegmann TG (1984) Fetal protection against abortion: is it immunosuppression or immunostimulation? Ann d' Immunol, 135D, 309-311.
Wegmann TG, Lin H, Guilbert L & Mosmann TR (1993) Bi-directional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today, 14, 353-356.
Williams GH, McLaughlin PJ & Johnson PM (1986) Tissue origin of serum placental-like alkaline phosphatase in cigarette smokers. Clin Chim Acta, 155, 329-334.